Lotte Biologics

Incheon, KR · Syracuse, NY
Find alternatives to Lotte Biologics for Biologics →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
81.6
Signal Score
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ✓ Press (20) ○ EMA GMP ○ MHRA GMP

Quick Facts: Lotte Biologics

Signal Score
81.6/100 (as of 2026-10-29)
Quality Compliance
100.0/100
Headquarters
Incheon, KR · Syracuse, NY
Modalities
Biologics, AAV
Active Programs
No ClinicalTrials.gov matches confirmed — 3 partnership signals in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Lotte Biologics

Korean conglomerate entering biologics CDMO. $1.6B investment.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-09-18)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 3 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: Lotte Group
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Lotte Group
Financial assessment: 68.0/100
Capacity 63.0
2 manufacturing sites
Sites: Incheon, South Korea, Syracuse, NY
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals20 articles (not scored)
2 manufacturing sites

Lotte Biologics FDA Inspection History

2026-09
2024-09
NAI VAI OAI
Date Site Type 483 citations posted Classification
2026-09-18
LOTTE Biologics USA, LLC
East Syracuse, New York Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
2024-09-19
Lotte Biologics USA, LLC
East Syracuse, New York Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

biologics, general (non-sterile) · 1 site

  • East Syracuse, United States · Lotte Biologics USA, LLC — biologics, general (non-sterile) · valid to Dec 31, 2027

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity 8 open roles Beta

From public job postings on Lotte Biologics' careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
8
open roles
4
in manufacturing, quality, PD/MSAT, engineering or regulatory (50%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 0 taken down.
By function
Manufacturing & operations 2
Engineering & facilities 2
Commercial, BD & client projects 1
Other (finance, HR, IT, other) 3
By site
Syracuse, NY profile site
2 mfg/ops · 2 eng. · 3 other
7
California, Washington, Oregon, Nevada, or Arizona
· 1 other
1
Modality words in job titles
Biologics (cell culture, USP/DSP)1
Notable roles
Associate Director, Procurement Senior operations / quality role · Syracuse, NY
Latest postings
Sr. Automation Controls Engineer - Platform Engineering Engineering & facilities · Syracuse, NY · posted Nov 17, 2026
Director, US Business Development & Sales (Western US Territory) Commercial, BD & client projects · California, Washington, Oregon,... · posted Nov 16, 2026
Director, IT Other (finance, HR, IT, other) · Syracuse, NY · posted Nov 5, 2026
Bioprocess Associate I (Downstream) - Nights Manufacturing & operations · Syracuse, NY · posted Nov 2, 2026
Associate Director, Procurement Manufacturing & operations · Syracuse, NY · posted Oct 28, 2026
HR Associate III (Payroll & Benefits) Other (finance, HR, IT, other) · Syracuse, NY · posted Oct 23, 2026
EHS Manager Other (finance, HR, IT, other) · Syracuse, NY · posted Aug 21, 2026
Senior Engineer, Bioconjugation Operations Engineering & facilities · Syracuse, NY · posted Mar 27, 2026
Coverage: counted from Lotte Biologics' own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: job-boards.greenhouse.io · Checked Nov 20, 2026 · Tracking since Oct 26, 2026

Company Signals 20 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-25
Rakuten Cancer Drug Data Boosts Lotte Biologics Outlook - Seoul Economic Daily
Rakuten Cancer Drug Data Boosts Lotte Biologics Outlook  Seoul Economic Daily
partnership 2026-10-07
Lotte Biologics expands US manufacturing partnership with Alvotech - The Korea Herald
Lotte Biologics expands US manufacturing partnership with Alvotech  The Korea Herald
general 2026-10-07
Lotte Biologics to manufacture Alvotech antibody biosimilars at Syracuse plant - Korea Biomedical Review
Lotte Biologics to manufacture Alvotech antibody biosimilars at Syracuse plant  Korea Biomedical Review
partnership 2026-10-07
Lotte Biologics partners with Alvotech to make biosimilars in New York - Chosunbiz
Lotte Biologics partners with Alvotech to make biosimilars in New York  Chosunbiz
general 2026-10-07
Lotte Biologics Wins Alvotech Biosimilar Order, Expands U.S. Syracuse Output - Seoul Economic Daily
Lotte Biologics Wins Alvotech Biosimilar Order, Expands U.S. Syracuse Output  Seoul Economic Daily
general 2026-10-07
Lotte Biologics announced on the 7th that it has signed a production order contract with global bios.. - 매일경제
Lotte Biologics announced on the 7th that it has signed a production order contract with global bios..  매일경제
general 2026-10-06
Alvotech And Lotte Biologics Announce US-Based Manufacturing Agreement To Increase Global Supply - TradingView
Alvotech And Lotte Biologics Announce US-Based Manufacturing Agreement To Increase Global Supply  TradingView
general 2026-10-06
Lotte Biologics Wins Contract to Manufacture Alvotech Biosimilar Drug Substance - BigGo Finance
Lotte Biologics Wins Contract to Manufacture Alvotech Biosimilar Drug Substance  BigGo Finance
regulatory 2026-04-27
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition  MSN
regulatory 2026-04-27
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition  MSN
general 2026-04-24
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate  MSN
general 2026-04-24
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate  MSN
general 2026-04-23
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate  MSN
general 2026-04-23
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate  MSN
regulatory 2026-04-18
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition  MSN
general 2026-04-15
Lotte Biologics to showcase SoluFlex Link ADC platform at AACR 2026 - koreabiomed.com
Lotte Biologics to showcase SoluFlex Link ADC platform at AACR 2026  koreabiomed.com
general 2026-04-12
LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract - Contract Pharma
LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract  Contract Pharma
partnership 2026-04-06
LOTTE Biologics Secures Partnership with a Japan-Based Global Pharmaceutical Companyobal Pharmaceutical Company - businesskorea.co.kr
LOTTE Biologics Secures Partnership with a Japan-Based Global Pharmaceutical Company  Businesskorea
general 2026-04-06
Lotte Biologics Signs Contract Development and Manufacturing Agreement for Anticancer Drug with Japanese Pharmaceutical Company - 아시아경제
Lotte Biologics Signs Contract Development and Manufacturing Agreement for Anticancer Drug with Japanese Pharmaceutical Company  아시아경제
general 2026-04-06
Lotte Biologics secures Japan CDMO deal to advance cancer drug development - CHOSUNBIZ - Chosunbiz
Lotte Biologics secures Japan CDMO deal to advance cancer drug development - CHOSUNBIZ  Chosunbiz

Frequently Asked Questions About Lotte Biologics

How many FDA inspections does Lotte Biologics have on record?
CDMO Signal tracks 2 FDA inspections for Lotte Biologics, sourced from the FDA inspection database. See the full inspection history above.
Has Lotte Biologics received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Lotte Biologics.
What is Lotte Biologics's CDMO Signal Score?
Lotte Biologics has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Lotte Biologics for a manufacturing program?
Use the free AI matchmaker to compare Lotte Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → AAV CDMOs →

Similar CDMOs

FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Northway Biotech
Vilnius, LT; Waltham (MA), USA
Signal Score: 80.8
Biologics, mAbs, Recombinant proteins, pDNA, AAV, Viral vectors, Gene Therapy
ProBioGen
Berlin, DE
Signal Score: 78.1
AAV, Lentiviral, Biologics

Compare Lotte Biologics with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Lotte Biologics
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.